March 2014

ACC.14: Metformin unproven as preventive therapy after STEMI ()
ACC.14: STAMPEDE gallops forward with promising results at 3 years ()
ACC.14: Clonidine fails to offer post-op MI benefit ()
ACC.14: Workflow disruptions drag down surgical quality ()
ACC.14: Don’t wait for ICD-10 to get more specific in coding ()
ACC.14: Melody implant results beat performance goal ()
ACC.14: Balance is key to avoiding burnout ()
ACC.14: Finding a cardiology job requires a broad network ()
ACC.14: CRT-D may improve survival in some heart failure patients ()
ACC.14: Darapladib may not affect development of coronary plaque ()
ACC.14: For procedural success, balloon-expandable valve may be better CHOICE ()
ACC.14: Dana Carvey, not your everyday opener ()
ACC.14: Learning curve, test limits may have derailed SYMPLICITY ()
ACC.14: ACC president touts IT progress ()
ACC.14: Cardiovascular disease guidelines may not be best risk estimators ()
ACC.14: ACC/AHA cardiovascular risk tool well calibrated ()
ACC.14: Erectile benefit offers another reason follow statin regimen ()
ACC.14: CoreValve meets superiority mark in high-risk patients ()
ACC.14: Genomics, other research poised to transform care ()
Pitt study examines benefits of depression treatment for heart failure patients ()
History is made with first small left ventricular assist device implant for young patient ()
ACC.14: Marriage associated with lower cardiovascular risk ()
ACC.14: Number of live births may affect cardiovascular risk ()
ACC.14: One-third of children may have elevated cholesterol levels ()
eCardio to highlight EMR integration expertise for remote monitoring customers at upcoming conferences ()
History is made with first small left ventricular assist device implant for young patient ()
Pitt study examines benefits of depression treatment for heart failure patients ()
Christiana Care Health System pioneers U.S. trial of absorbable scaffold for heart patients ()
March madness ()
Hit in the solar plexus for emergency rooms ()
Duke pays $1M to settle case over cardiac services ()
MPI use drops by 51 percent over 5-year span ()
FDA approves 3 pacemaker devices ()
Heart-racing? NASCAR picks cardiovascular partner ()
Leadless pacemaker safe, effective at 90 days ()
Recalled leads illustrate fissures in FDA process ()
Surgery in stroke patients may improve survival, but not quality of life ()
Operators slice radiation dose by 48% after workshop ()
Carotid atherosclerosis score may help predict stroke risk ()
Singulex's proprietary ultrasensitive research test for cardiac troponin-I predicts coronary heart disease in the general population ()
Annals of Internal Medicine launches interactive CME- and MOC-accredited medical education tool ()
Bard announces first patient enrolled in Lutonix In-Stent Restenosis Clinical Trial ()
Corindus Vascular Robotics, Sanford Health and The Leona M. and Harry B. Helmsley Charitable Trust launch remote robotics program ()
St. Jude Medical announces start of European post-approval trial for Nanostim leadless pacemaker ()
Prominent cardiac cell biologist Jennifer Van Eyk, PhD, joins Cedars-Sinai to direct new advanced clinical biosystems research institute ()
Hawaii sues makers of Plavix ()
Many women unaware of stroke's warning signs ()
Talking statins ()
Guidelines swell ranks for statins by almost 13 million ()
'Bendopnea' identified as a possible symptom of heart failure ()
Maternal cardiac arrest more common than originally thought ()
Federal ORI charges cardiologist with misconduct ()
Proceed with caution ()
ACC.14: Will TAVR be the talk of the town? ()
ACC.14: Renal denervation, colchicine and registries among late-breakers ()
Guidelines on fat intake may need revision ()
2-year cost analysis favors SPECT for CAD testing ()
Feel the (heart) beat ()
Enrollment completed for EUCLID study in patients with peripheral artery disease ()
Cedars-Sinai Heart Institute sets new standard for most US heart transplants in a year ()
Continuity of care may lower costs for chronically ill older adults ()
Societies offer go-to resource for PCI centers without surgical backup ()
Results on value of stroke imaging may be misleading ()
Gender gap extends to treatment for acute coronary syndrome ()
Texas Heart Institute doctors participating in clinical study of new device to 'seal' abdominal aortic aneurysms ()
Boston Scientific receives CE Mark approval for REBEL platinum chromium coronary stent system ()
Boston Scientific announces CE Mark approval and first implants of Ingevity MRI pacing leads ()
Stroke in children will be focus of $3 million grant ()
New stroke research combines brain stimulation, gait training ()
Key heart-failure culprit discovered ()
FDA approves first ICD to be evaluated in US clinical trials for use in MRIs ()
Some older adults' meds can worsen coexisting conditions ()
FDA approves new indication for apixaban ()
Treating ruptured AAA: Clues to improve outcomes ()
Gestational diabetes may up risk of atherosclerosis ()
Discrepancies in reporting of trial results raise questions on accuracy ()
Review: Diabetes drug trials should add HF hospitalization as outcome ()
79% of cardiologists would repeat career choice ()
Dealing with D.C. ()
Boston Heart enables healthcare providers to better identify near-term risk of heart attack or stroke with launch of an important inflammation marker, myeloperoxidase (MPO) ()
AngioDynamics receives expanded FDA clearance for AngioVac ()
Cost-effectiveness of CAC scan depends on statin factors ()
Combat exposure may increase risk of heart disease ()
2 antibiotics linked to increased risk of death and serious arrhythmia ()
Registries in Transition ()
Report cards on outcomes at lower-volume hospitals may be skewed ()
ACC Corner | Avoiding a (Tera)Flop: Early Lessons in Healthcare Big Data ()
Imaging Systems: Better Care with Improved Efficiencies ()
Building a Better Cath Lab Report ()
‘One-Stop Shop’ Clinics Treat Heart Disease, Diabetes in Tandem ()
CMR may be better than SPECT at diagnosing CAD in women ()
Disappearing Act: From Coatings to Cage-free Coronaries ()
Q&A | ACC.14: Late-breaker Lessons ()
Physicians as Advocates: On Call in D.C. ()
Cardiologist Skorton to lead Smithsonian ()
Cardiovascular Systems receives FDA clearance for low profile, 60cm Diamondback devices designed to expand the treatment of peripheral artery disease (PAD) ()
Cardiovascular Care Group appoints new chief executive officer ()
ICD-CRT may lead to fewer hospitalizations than ICD alone ()
Trial tests use of email to motivate heart failure patients ()
Technically inoperable patients fare best after TAVR ()
Cloud-based platform may make ECG data easier to assess ()
FDA places another recall on Ranbaxy’s statin ()
Airsick but heart healthy ()
WMU and new medical school offer dual MD-MBA degree ()
Edwards Lifesciences announces first human implants with mitral transcatheter valve system ()
Newer cryoballoon scores on efficacy but with higher complication rate ()
Female docs spend more time parenting than male counterparts ()
USPSTF review finds benefits with AAA screening ()
LVAD bleeding risk varies based on patient factors ()
Report: Cath lab steers scheduled patients through ED ()
Pre-hospital stroke alerts expedite CT imaging ()
European office revokes patent on TAVR valve ()
Reasons behind variation in NSTEMI bleeding rates unclear ()
The SGR countdown ()
UltraSPECT and ASNC partner to provide technologist travel awards to attend ASNC2014 ()
ECGs as part of athlete screenings less favored in U.S. ()
Most employed physicians satisfied, with caveats ()
Obesity takes heavy toll on medical costs ()
Thoratec issues safety advisory after 4 deaths ()
Warfarin may benefit CKD patients without adding bleeding risk ()
Valvular heart disease guidelines add TAVR, updates ()
Inadequate nurse staffing tied to higher patient mortality ()
MRI IDs cardiovascular risk in asymptomatic people ()
Transradial PCI may lower risk of acute kidney injury ()
Report deems apixaban safest among anticoagulants ()
Aortic stenosis: Lifelong learning in the 21st century ()
CBO: Repealing SGR may cost additional $60B over 5 years ()